Company Search:
Advanced Search
Sponsored Links
argenx SE - ADR Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other companies in this sector in UNITED STATES : Adaptive Biotechnologies Corp (2019 sales of $85.07 million of which 100% was Biotechnology & Medical Research), Zyla Life Sciences ($81.30 million ), and MorphoSys AG ($80.20 million of which 52% was Partnered Discovery).

Sales Analysis. Sales increased substantially in 2019: argenx SE reported sales of $78.00 million for the year ending December of 2019. This represents an increase of 208.2% versus 2018, when the company's sales were $25.31 million. Sales of Research and Development Service Fees (F saw an increase that was more than double the company's growth rate: sales were up 1,203.8% in 2019, from $1.66 million to $21.62 million.
  Stock Performance Chart for argenx SE - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 230.76
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks -7.9%  
4 Weeks 54.8%   52 Weeks 62.2%  
argenx SE - ADR Key Data:
  Ticker: ARGX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 77,999,948
(Year Ending Jan 2020).
Employees: 188
  Currency: U.S. Dollars Market Cap: 10,870,757,229
  Fiscal Yr Ends: December Shares Outstanding: 47,108,499
  Share Type: ADR Closely Held Shares: 280,941
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.